The new rules, which apply to transmucosal immediate-release fentanyl (TIRF) drugs, state that providers should prescribe TIRF drugs only to opioid-tolerant patients and require prescribers to document and verify the patient's opioid tolerance, in today's bite-sized hospital and health industry news from Maryland, New York, and Virginia.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
1 free members-only resources remaining this month
1 free members-only resources remaining this month
You've reached your limit of free monthly insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free monthly insights